TENS Self-applied in the Complementary Treatment of Deep Endometriosis
Launched by UNIVERSITY OF CAMPINAS, BRAZIL · May 10, 2016
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
* Women will be selected to participate in the study between June 2016 to March 2018, from medical records research and routine queries in Endometriosis clinic of the Gynecology's Hospital of University of Campinas (UNICAMP) and the clinic of Gynecology (Endometriosis routine queries) of the Hospital of University of São Paulo (USP). All women will respond to the Check List for inclusion in the study and will sign an informed consent form.
* The women selected will be randomized into two distinct groups: follow-up/treatment - control group (CG) composed of two phases of 8 weeks each or trea...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women at reproductive age;
- • 18 and 50 years;
- • diagnosis of deep endometriosis (cul-de-sac and intestinal lesions);
- • using hormonal treatment at least 3 months;
- • persistence of chronic pelvic pain and/or dyspareunia.
- Exclusion Criteria:
- • Women with decreased skin sensitivity;
- • pregnant women;
- • women with pacemaker implants;
- • cutaneous hypersensitivity (allergic reactions to gel or electrode);
- • women with epilepsy;
- • cardiac (cardiac arrhythmia);
- • osteosynthesis in the application place;
- • a solution of discontinuity of the skin;
- • malignant tumors;
- • acute inflammatory disease;
- • other gynecological associated pathologies;
- • a cognitive deficiency that precludes the understanding of instruments and/or instructions for self-applied of TENS.
About University Of Campinas, Brazil
The University of Campinas (Universidade Estadual de Campinas, UNICAMP) is a prestigious research institution located in Brazil, renowned for its commitment to advancing knowledge and innovation in the medical and scientific fields. With a strong emphasis on interdisciplinary collaboration, UNICAMP conducts cutting-edge clinical trials aimed at improving healthcare outcomes and developing novel therapeutic approaches. The university leverages its extensive resources, including state-of-the-art laboratories and a team of highly qualified researchers and clinicians, to contribute significantly to the global body of medical research while fostering education and training in clinical and translational sciences.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Campinas, São Paulo, Brazil
Patients applied
Trial Officials
Ticiana AA Mira, MSc
Principal Investigator
University of Campinas
Cristina L Benetti-Pinto, PhD
Study Chair
University of Campinas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials